Research Day 2022

Friday, October 28, 2022
0830-1600 MT

1-040 Oborowsky Degner Seminar Hall
Li Ka Shing Centre for Health Research Innovation

September 12 ABSTRACT SUBMISSION DEADLINE
September 26 NOTIFICATION OF ACCEPTANCE
October 17 EVENT REGISTRATION OPENS

KEYNOTE SPEAKER

Dr. Peter J. Thompson, Assistant Professor

Department of Physiology & Pathophysiology
University of Manitoba

ABSTRACT SUBMISSION Instructions

If your supervisor is an ADI Member, you are an ADI Trainee! All ADI Trainees (summer students, graduate students, postdoctoral fellows, research associates) are welcome to submit their abstract.


Event details

The 2022 ADI Research Day will be held in-person at the Li Ka Shing Centre for Health Research Innovation in the Oborowsky Degner Seminar Hall (1-040 LKS) and the LKS Foyer from 0830-1600 MT. 

The Keynote Speaker in-person presentation by Dr. Thompson will be from 0845-0945 MT offered in hybrid format (zoom link details will be provided at a later date). 

Trainee presentations will be held in-person, there will be podium and poster format presentations.

The full program with complete details will be updated on this website closer to the date.


Peter J. Thompson, PhD

ADI is excited to announce this year's keynote speaker is Dr. Peter J. Thompson. Dr. Thompson is an Assistant Professor in the Department of Physiology & Pathophysiology at the University of Manitoba and a Principal Investigator in the Children’s Hospital Research Institute of Manitoba. He earned his BSc in molecular genetics (2007) and MSc in molecular biology (2010) at the University of Alberta, where his thesis characterized the roles of chromatin remodelling factors in mammalian development and the germline in the lab of Dr. Heather McDermid. He completed his PhD in medical genetics (2016) at the University of British Columbia in the lab of Dr. Matthew Lorincz, where he studied epigenetic mechanisms of gene regulation in embryonic stem cells. He moved into the fields of islet biology and diabetes during his postdoctoral fellowship at the University of California San Francisco (UCSF, 2016-2020), where his work discovered senescence as a new form of beta cell dysfunction in type 1 diabetes (T1D). He was funded by the Diabetes Research Connection, the Larry L. Hillblom Foundation and the Program for Breakthrough Biomedical Research at UCSF. He started his independent position at the University of Manitoba and Children’s Hospital Research Institute of Manitoba in 2020, where his research program explores beta cell stress responses and their crosstalk with the immune system in the pathogenesis of T1D with the goal of developing new therapies.